Literature DB >> 19236494

Systematic reviews as a tool for planning and interpreting trials.

Philip M W Bath1, Laura J Gray.   

Abstract

BACKGROUND: Systematic reviews followed by a meta-analysis are carried out in medical research to combine the results of two or more related studies. Stroke trials have struggled to show beneficial effects and meta-analysis should be used more widely throughout the research process to either speed up the development of useful interventions, or halt more quickly research with hazardous or ineffective interventions. SUMMARY OF REVIEW: This review summarises the clinical research process and illustrates how and when systematic reviews may be used throughout the development programme. Meta-analyses should be performed after observational studies, preclinical studies in experimental stroke, and after phase I, II, and III clinical trials and phase IV clinical surveillance studies. Although meta-analyses most commonly work with summary data, they may be performed to assess relationships between variables (meta-regression) and, ideally, should utilise individual patient data. Meta-analysis techniques may also work with ordered categorical outcome data (ordinal meta-analysis) and be used to perform indirect comparisons where original trial data do not exist.
CONCLUSION: Systematic review/meta-analyses are powerful tools in medical research and should be used throughout the development of all stroke and other interventions.

Entities:  

Mesh:

Year:  2009        PMID: 19236494     DOI: 10.1111/j.1747-4949.2009.00235.x

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  3 in total

Review 1.  Do stroke models model stroke?

Authors:  Philipp Mergenthaler; Andreas Meisel
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

Review 2.  Phase 4 Studies in Heart Failure - What is Done and What is Needed?

Authors:  Pupalan Iyngkaran; Danny Liew; Peter McDonald; Merlin C Thomas; Christopher Reid; Derek Chew; David L Hare
Journal:  Curr Cardiol Rev       Date:  2016

3.  Redundant trials can be prevented, if the EU clinical trial regulation is applied duly.

Authors:  Daria Kim; Joerg Hasford
Journal:  BMC Med Ethics       Date:  2020-10-28       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.